Interview: Peter Gmünder – CEO, Bioforce AG, Switzerland

SONY DSCWith a recent clinical trial showing one of Bioforce’s Echinacea products to be non-inferior to the gold standard allopathic treatment Tamiflu, CEO Peter Gmünder is working to continue the work of Swiss phytopharmaceuticals pioneer Alfred Vogel by providing the highest quality natural remedies made using only fresh herbs if possible. To begin, could you please introduce Bioforce to our readers around the world?
"We quite literally grow our herbs next door, with our fields surrounding our manufacturing facility, to ensure the freshness of our raw materials."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report